Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 293.40 |
---|---|
High | 294.00 |
Low | 291.10 |
Bid | 297.00 |
Offer | 297.50 |
Previous close | 294.00 |
Average volume | -- |
---|---|
Shares outstanding | 72.23m |
Free float | 72.19m |
P/E (TTM) | 67.69 |
Market cap | 38.80bn CHF |
EPS (TTM) | 7.94 CHF |
Annual div (ADY) | 4.08 EUR |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | May 13 2024 |
Div pay-date | May 15 2024 |
Data delayed at least 15 minutes, as of Jun 28 2019.
More ▼
Announcements
- Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024
- Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
- Lonza Nominates David Meline as Independent Board Member
- Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
- Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
- Lonza Prices EUR 1.2 Billion Dual-Tranche Straight Bonds
More ▼